Company Filing History:
Years Active: 2022-2024
Title: The Innovations of Patricia Gräf in Cell Culturing
Introduction
Patricia Gräf stands out as a significant inventor in the field of biotechnology, particularly in the methods of culturing cells. Based in Munich, Germany, her expertise and innovative approaches have led to the acquisition of two patents, enhancing our understanding of cell behavior and interaction.
Latest Patents
Patricia's latest patents revolve around advanced methods for culturing cells. These inventions focus on stimulating or expanding populations of lymphocytes, crucial in various therapeutic practices. The patented methods involve binding agents to molecules on the surface of the cells, delivering signals that prompt expansion and proliferation. Reversible bonds enable the removal of stimulatory agents, allowing for controlled cell behavior, which has significant implications in research and therapeutic applications.
Career Highlights
Currently, Patricia Gräf is affiliated with Juno Therapeutics GmbH. Her work primarily interacts with innovative approaches in cell culture technology, aiming to improve the effectiveness of cellular therapies. With her two patents, she contributes to the advancement of biotechnological solutions that can lead to groundbreaking treatments in medicine.
Collaborations
Patricia collaborates with noteworthy colleagues, including Lothar Germeroth and Christian Stemberger. Their combined expertise fosters an environment of innovation and research, further amplifying the impact of their collective work in cellular therapeutics at Juno Therapeutics GmbH.
Conclusion
As an inventor, Patricia Gräf's contributions to the field of cell culturing reflect her dedication and innovative spirit. Her patents not only advance scientific knowledge but also pave the way for novel therapeutic applications, positioning her as a key figure in biotechnological research and development.